The goal of this clinical trial is to test the safety of the use of non-thermal plasma (NTP, an ionized gas) on the tumor bed after the removal of the tumor in breast cancer patients. The main questions it aims to answer are:
* To determine the safe and tolerable dose of NTP in patients with breast cancer; * To assess the safety and tolerability of NTP; * To assess the cosmetic effects of NTP treatment in patients with breast cancer. Participants will receive one treatment of the tumor bed after the removal of their breast tumor.
Age ≥18 years at the time of signing study consent.
ECOG ≤2.
Patient with T1-4 breast cancer for groups A and B; patient with T1/T2 breast cancer for group C (based on physical exam, not radiological measurements).
Patient is scheduled to undergo a lumpectomy.
Prior treatment for the tumor of interest (including chemotherapy, immunotherapy, radiotherapy).
Patient planning to or undergoing intraoperative radiotherapy.
Diabetes (types I and II).
Hypercortisolism.
Centre hospitalier de l'Université de Montréal (CHUM)
Lead sponsor
Ozmosis Research Inc.
Collaborator
Quebec Breast Cancer Foundation
Collaborator